Aizant is an integrated provider of drug development services with distinctive capabilities in formulating finished dosages with a proprietary portfolio of specialty generics. It also provides bio-analytical services, clinical services, and manufacturing services to marquee clients.

The Company’s manufacturing and clinical facilities are approved by regulators from USA, Canada, Europe, Brazil, Russia, China, Australia, and Africa.